Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinicopathological features
Authors:
- Qianming ChenQCQianming Chen
- Bingqi LiBLBingqi Li
- Xin ZengXZXin Zeng
- 31 May 2007
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 43 (5) , 508-514
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Recurrent coamplification of cytoskeleton‐associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinomaGenes, Chromosomes and Cancer, 2005
- DNA copy number gains in head and neck squamous cell carcinomaOncogene, 2005
- Array-Based Comparative Genomic Hybridization Analysis Identified Cyclin D1 as a Target Oncogene at 11q13.3 in Nasopharyngeal CarcinomaCancer Research, 2005
- High‐throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancerThe Journal of Pathology, 2003
- High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1 , that is amplified and overexpressed in oral cancer cellsProceedings of the National Academy of Sciences, 2002
- Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle controlOral Oncology, 2000
- Markers of proliferation in normal and leukoplakic oral epitheliaOral Oncology, 2000
- Characterization of the EMS1 Gene and its Product, Human CortactinCell Adhesion and Communication, 1998
- Chromosome 11q13 Amplification in Head and Neck Squamous Cell Carcinoma: Association With Poor PrognosisJAMA Otolaryngology–Head & Neck Surgery, 1995
- The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes-a reviewGene, 1995